HLS Therapeutics Inc T.HLS

Alternate Symbol(s): HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.

TSX:HLS - Post by User

HLS Therapeutics Inc

Bullboard Posts

Comment by PAGODA5on May 15, 2013 11:11am

84 Views

Post# 21394538

RE: RE: RE: TheRock

Take a gander at the chart of this baby....yowza what a collapse.

I actually like to see this type of thing because it provides a opportunity for the classic bounce off the bottom. I just bought some at $1.30 and look to sell this around $1.40. There are plenty of Rock heads out there that will run this back up.

Bullboard Posts

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload